VanEck Vectors Pharmaceutical (PPH)
Outlooks:
![](http://www.maxfunds.com/images/rolloverQuestion.gif)
Forecast:![]() |
4% |
Best Case:![]() |
31% |
Worst Case:![]() |
-45% |
EXPENSES
Cost Per $10,000:
![](http://www.maxfunds.com/images/rolloverQuestion.gif)
3-Year: | $116 |
5-Year: | $204 |
10-Year: | $464 |
Loads and Fees:
![](http://www.maxfunds.com/images/rolloverQuestion.gif)
Initial: | 0% |
Deferred: | 0% |
Redemption: | 0% |
12b-1: | NONE |
PERFORMANCE
Avg. Annualized Returns Vs. All Funds
![](http://www.maxfunds.com/images/rolloverQuestion.gif)
1-Year: | 18.29% | ||
3-Year: | 9.83% | ||
5-Year: | 11.3% |
Avg. Annualized Returns Vs. Similar Funds
Show Details
![](http://www.maxfunds.com/images/rolloverQuestion.gif)
1-Year: | 7.62% | ||
3-Year: | 10.41% | ||
5-Year: | 1.93% |
MANAGEMENT
Fund Manager:
![](http://www.maxfunds.com/images/rolloverQuestion.gif)
Name: | Team Managed |
Since: | 12/20/2011 |
RESOURCES
Contact Info:![](http://www.maxfunds.com/images/rolloverQuestion.gif)
![](http://www.maxfunds.com/images/rolloverQuestion.gif)
n/a800 826-2333
NTF Availability:![](http://www.maxfunds.com/images/rolloverQuestion.gif)
![](http://www.maxfunds.com/images/rolloverQuestion.gif)
E*Trade
TD Ameritrade
Charles Schwab
Firstrade
Vanguard